HCP (NYSE:HCP) will post its quarterly earnings results after the market closes on Wednesday, October 30th. Analysts expect HCP to post earnings of $0.43 per share for the quarter. HCP has set its FY19 guidance at $1.73-1.77 EPS.Individual interested in listening to the company’s earnings conference call can do so using this link.
HCP (NYSE:HCP) last released its quarterly earnings results on Wednesday, July 31st. The real estate investment trust reported ($0.03) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.43 by ($0.46). The firm had revenue of $489.15 million for the quarter, compared to analyst estimates of $444.67 million. HCP had a net margin of 53.57% and a return on equity of 15.54%. The firm’s quarterly revenue was up 4.5% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.45 EPS. On average, analysts expect HCP to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.
HCP stock opened at $37.52 on Wednesday. The firm has a market cap of $18.36 billion, a PE ratio of 20.62, a P/E/G ratio of 6.96 and a beta of 0.23. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.90 and a current ratio of 0.90. The firm’s fifty day moving average is $35.74 and its 200 day moving average is $32.93. HCP has a one year low of $25.82 and a one year high of $37.87.
In other HCP news, COO Thomas Klaritch sold 35,014 shares of the stock in a transaction on Wednesday, September 4th. The shares were sold at an average price of $36.02, for a total transaction of $1,261,204.28. Following the transaction, the chief operating officer now directly owns 230,529 shares of the company’s stock, valued at $8,303,654.58. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Company insiders own 0.13% of the company’s stock.
HCP Company Profile
HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.
Read More: Insider Trading
Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.